COVID-19: Melatonin as a potential adjuvant treatment

R Zhang, X Wang, L Ni, X Di, B Ma, S Niu, C Liu… - Life sciences, 2020 - Elsevier
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19
based on its putative pathogenesis. The recent outbreak of COVID-19 has become a …

The safety of melatonin in humans

LPH Andersen, I Gögenur, J Rosenberg… - Clinical drug …, 2016 - Springer
Exogenous melatonin has been investigated as treatment for a number of medical and
surgical diseases, demonstrating encouraging results. The aim of this review was to present …

Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial

B Wibrow, FE Martinez, E Myers, A Chapman… - Intensive Care …, 2022 - Springer
Purpose Delirium is common in the critically ill, highly distressing to patients and families
and associated with increased morbidity and mortality. Results of studies on preventative …

Clinical pharmacokinetics of melatonin: a systematic review

NG Harpsøe, LPH Andersen, I Gögenur… - European journal of …, 2015 - Springer
Purpose The aim of the review was to provide an overview of studies investigating the
pharmacokinetics of exogenous melatonin in humans and if possible, to provide …

Melatonin: action as antioxidant and potential applications in human disease and aging

D Bonnefont-Rousselot, F Collin - Toxicology, 2010 - Elsevier
This review aims at describing the beneficial properties of melatonin related to its antioxidant
effects. Oxidative stress, ie, an imbalance between the production of reactive oxygen …

Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model

NJ Robertson, S Faulkner, B Fleiss, A Bainbridge… - Brain, 2013 - academic.oup.com
Despite treatment with therapeutic hypothermia, almost 50% of infants with neonatal
encephalopathy still have adverse outcomes. Additional treatments are required to …

Melatonin target proteins: too many or not enough?

L Liu, N Labani, E Cecon, R Jockers - Frontiers in endocrinology, 2019 - frontiersin.org
The neurohormone N-acetyl-5-methoxytryptamine, better known as melatonin, is a
tryptophan derivative with a wide range of biological effects that is present in many …

[HTML][HTML] Feeding mitochondria: Potential role of nutritional components to improve critical illness convalescence

E Wesselink, WAC Koekkoek, S Grefte, RF Witkamp… - Clinical Nutrition, 2019 - Elsevier
Persistent physical impairment is frequently encountered after critical illness. Recent data
point towards mitochondrial dysfunction as an important determinant of this phenomenon …

[HTML][HTML] Melatonin for the treatment of sepsis: the scientific rationale

RMLC Biancatelli, M Berrill… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Sepsis affects 30 million people worldwide, leading to 6 million deaths every year (WHO),
and despite decades of research, novel initiatives are drastically needed. According to the …

Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis

HF Galley, DA Lowes, L Allen… - Journal of pineal …, 2014 - Wiley Online Library
Sepsis is a massive inflammatory response mediated by infection, characterized by
oxidative stress, release of cytokines, and mitochondrial dysfunction. Melatonin accumulates …